XML 100 R55.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2019
USD ($)
$ / shares
Sep. 30, 2019
USD ($)
$ / shares
Jun. 30, 2019
USD ($)
$ / shares
Mar. 31, 2019
USD ($)
$ / shares
Dec. 31, 2018
USD ($)
$ / shares
Sep. 30, 2018
USD ($)
$ / shares
Jun. 30, 2018
USD ($)
$ / shares
Mar. 31, 2018
USD ($)
$ / shares
Dec. 31, 2019
USD ($)
yr
$ / shares
Dec. 31, 2018
USD ($)
$ / shares
Dec. 31, 2017
USD ($)
$ / shares
Goodwill [Line Items]                      
Percentage Fair Value of Goodwill Exceeded Carrying Value 10.00%               10.00%    
Value of Reporting Unit's Goodwill $ 2,200.0               $ 2,200.0    
Revenues 2,953.4 $ 2,928.5 $ 2,881.7 $ 2,791.2 $ 2,787.5 $ 2,831.3 $ 2,866.3 $ 2,848.3 11,554.8 $ 11,333.4 $ 10,308.0
Cash, Uninsured Amount 335.0       423.0       335.0 423.0  
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification                 $ 1.6 10.2 16.9
Finite-Lived Intangible Asset, Useful Life                 15 years    
Cost of Revenue                 $ 8,302.3 8,157.0 7,216.2
Gross profit 820.7 817.3 824.8 789.7 772.4 789.9 835.1 779.0 3,252.5 3,176.4 3,091.8
Selling, general and administrative expenses                 1,624.5 1,570.9 1,499.2
Nonoperating Income (Expense)                 (225.3) (57.4) (227.7)
Income Tax Expense (Benefit)                 280.0 384.4 (155.4)
Net earnings                 824.9 883.9 1,232.9
Net Income (Loss) Attributable to Noncontrolling Interest                 (1.1) (0.2) (5.8)
Net earnings attributable to Laboratory Corporation of America Holdings $ 227.1 $ 220.7 $ 190.4 $ 185.6 $ 157.9 $ 318.8 $ 233.8 $ 173.2 $ 823.8 $ 883.7 $ 1,227.1
Earnings Per Share, Basic | $ / shares $ 2.34 $ 2.26 $ 1.94 $ 1.88 $ 1.58 $ 3.14 $ 2.29 $ 1.70 $ 8.42 $ 8.71 $ 11.99
Earnings Per Share, Diluted | $ / shares $ 2.32 $ 2.25 $ 1.93 $ 1.86 $ 1.56 $ 3.10 $ 2.27 $ 1.67 $ 8.35 $ 8.61 $ 11.81
Net Cash Provided by (Used in) Operating Activities                 $ 1,444.7 $ 1,305.4 $ 1,498.1
Prior Period Reclassification Adjustment                   44.4  
Net Cash Provided by (Used in) Investing Activities                 (1,283.1) 206.7 (2,228.7)
Net Cash Provided by (Used in) Financing Activities                 (252.7) (1,389.9) 593.2
Effect of exchange rate changes on cash and cash equivalents                 1.8 (12.0) 20.5
Cash and Cash Equivalents, Period Increase (Decrease)                 $ (89.3) 110.2 (116.9)
Percentage Change in Discount Rate Used to Calculate Fair Value of Goodwill 1.00%               1.00%    
Percentage Fair Value Exceeds Carrying Value with a 1% Change in Discount Rate Used to Calculate Fair Value of Goodwill 1.00%               1.00%    
Greater Than Lease Term Months Required to Record Right of Use Asset and Lease Liability                 12 years    
Less Than Initial Lease Term Months For Short Term Lease Exemption and Recording on Balance Sheet                 12 years    
Goodwill $ 7,865.0       $ 7,360.3       $ 7,865.0 7,360.3 7,400.9
Derivative, Fair Value, Net 0.0               0.0    
Other Inventory, Supplies, Gross 228.3       200.1       228.3 200.1  
Inventory, Finished Goods, Gross 16.4       37.2       $ 16.4 37.2  
Ownership percentage below which investments are generally accounted for on the cost method (in hundredths)                 20.00%    
Accounts receivable balances (gross) from Medicare and Medicaid $ 81.4       88.8       $ 81.4 88.8  
Estimated useful life of capitalized software costs (in years) | yr                 5    
Minimum threshold percentage required to recognize income tax benefit (in hundredths) 50.00%               50.00%    
Accounts receivable from Ontario government sponsored healthcare plan $ 3.2       $ 0.5       $ 3.2 $ 0.5  
Percent of gross accounts receivable due from patients 21.10%       21.50%       21.10% 21.50%  
Minimum [Member] | Customer Relationships [Member]                      
Goodwill [Line Items]                      
Finite-Lived Intangible Asset, Useful Life                 10 years    
Minimum [Member] | Patents, Licenses And Technology [Member]                      
Goodwill [Line Items]                      
Finite-Lived Intangible Asset, Useful Life                 3 years    
Minimum [Member] | Non-compete agreements [Member]                      
Goodwill [Line Items]                      
Finite-Lived Intangible Asset, Useful Life                 3 years    
Minimum [Member] | Trade Names [Member]                      
Goodwill [Line Items]                      
Finite-Lived Intangible Asset, Useful Life                 1 year    
Maximum [Member] | Customer Relationships [Member]                      
Goodwill [Line Items]                      
Finite-Lived Intangible Asset, Useful Life                 36 years    
Maximum [Member] | Patents, Licenses And Technology [Member]                      
Goodwill [Line Items]                      
Finite-Lived Intangible Asset, Useful Life                 15 years    
Maximum [Member] | Non-compete agreements [Member]                      
Goodwill [Line Items]                      
Finite-Lived Intangible Asset, Useful Life                 5 years    
Maximum [Member] | Trade Names [Member]                      
Goodwill [Line Items]                      
Finite-Lived Intangible Asset, Useful Life                 15 years    
LabCorp Diagnostics [Member]                      
Goodwill [Line Items]                      
Revenues                 $ 7,000.1 $ 7,030.8 6,858.2
Goodwill $ 3,721.5       $ 3,638.8       3,721.5 3,638.8 3,673.9
Covance Drug Development [Member]                      
Goodwill [Line Items]                      
Revenues                 4,578.1 4,313.1 3,451.6
Goodwill $ 4,143.5       $ 3,721.5       $ 4,143.5 $ 3,721.5 $ 3,727.0